Advanced Search

Home Health & Hospice Week

Hospice:

DEA Telehealth Limitation Holds Back Hospice Care

Published on Fri May 22, 2020

Nix visual requirement, industry experts urge Medicare. Hospices hoping to see flexibility for their patients regarding telehealth and prescribing controlled substances are so far disappointed. The Drug Enforcement Agency said on March 16 that “DEA-registered practitioners ... may issue prescriptions for all schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation” with certain [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Home Health & Hospice Week

View All